Company Monitoring Page for Endocyte

latest headlines for company on cafepharma

Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
Motley Fool
Mon, 05/2/22 - 11:57 am
Tags:
Novartis, M&A, AveXis, Zolgensma, Endocyte, Pluvicto, The Medicines Company, Levqio
Endocyte deal showcases Novartis' complex manufacturing juggling act
Biopharma Dive
Thu, 10/25/18 - 11:25 pm
Tags:
Novartis, Endocyte, earnings, drug manufacturing
Crazy biotech: Endocyte reaches 2-billion value over few months
GoinPharma
Sun, 10/21/18 - 11:34 pm
Tags:
Endocyte
Novartis buys Endocyte for $2.1B in latest deal under CEO Narasimhan
Biopharma Dive
Thu, 10/18/18 - 01:08 pm
Tags:
Novartis, earnings, M&A, Endocyte
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
Tags:
prostate cancer, JNJ, Zytiga, Erleada, Pfizer, Astellas, Xtandi, AbbVie, Lupron, Endocyte, Lu-PSMA-617
With clear regulatory path, Endocyte raises $175M
BioCentury
Tue, 09/11/18 - 11:29 pm
Tags:
Endocyte, 177Lu-PSMA-617
The 4 Best Biotech Stocks of 2018 (So Far)
Motley Fool
Sat, 07/14/18 - 01:22 pm
Tags:
biotech, Arrowhead Research, Endocyte, Arqule, Madrigal Pharmaceuticals
3 Huge Biotech Winners in 2018 (So Far)
Motley Fool
Wed, 07/11/18 - 10:17 am
Tags:
biotech, Arrowhead Pharmaceuticals, Endocyte, Madrigal Pharmaceuticals
4 Biotech Stocks That Tripled in the First Half of 2018
Motley Fool
Mon, 07/2/18 - 10:17 pm
Tags:
biotech, biotech stocks, Arrowhead Pharmaceuticals, Arqule, Endocyte, Madrigal Pharmaceuticals
The 3 Best Biotech Stocks of 2018 So Far
Motley Fool
Sat, 06/30/18 - 11:52 am
Tags:
Innovate Biopharmaceuticals, Arrowhead Pharmaceuticals, Endocyte
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
Tags:
ASCO 2018, European Society of Cardiology, TherapeuticsMD, Abiomed, Incyte, Bluebird Bio, Celgene, Syndax, Loxo Oncology, Exelixis, Karyopharm, Endocyte, Celldex Therapeutics, Jounce Therapeutics, Bristol-Myers Squibb, Nektar
Winners and Losers From the Biggest Cancer Meeting of the Year (So Far)
Motley Fool
Fri, 05/18/18 - 10:00 pm
Tags:
ASCO, Endocyte, Loxo Oncology, Blueprint Medicines, Nektar Therapeutics, Jounce Therapeutics
3 Drug Stocks That Soared This Week
Motley Fool
Sun, 10/8/17 - 11:26 am
Tags:
Endocyte, PSMA-617, MannKind, Afrezza, Mylan Labs, generics, Teva Pharmaceutical
Prescribed Reading: DMD, MS and other acronyms
Biopharma Dive
Sun, 10/8/17 - 11:22 am
Tags:
Celgene, Nimbus, Endocyte, Amicus Therapeutics, Catabasis, Motif Biosciences
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal
Xconomy
Mon, 10/2/17 - 11:07 am
Tags:
Endocyte, prostate cancer, ABX, PSMA-617
Endocyte slumps on staff and R&D cuts
BioPharma Dive
Wed, 06/7/17 - 10:06 am
Tags:
Endocyte, layoffs, R&D
Endocyte slashes staff and retrenches in the wake of back-to-back R&D setbacks
Endpoints
Fri, 06/2/17 - 10:42 am
Tags:
Endocyte, layoffs, R&D, EC1456
Endocyte reports first-quarter loss but meets expectations
Yahoo/AP
Wed, 05/4/16 - 08:53 am
Tags:
Endocyte, earnings
Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients
Yahoo
Tue, 09/8/15 - 08:08 am
Tags:
Endocyte, vintafolide, clinical trials, non-small cell lung cancer
Should Endocyte abandon a cancer drug that works?
Indianapolis Business Journal, IN
Tue, 09/30/14 - 12:44 pm
Tags:
Endocyte, vintafolide, lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.